The role of transperineal template biopsies of the prostate in the diagnosis of prostate cancer: a review

References

• Prostate cancer incidence statistics. Cancer research UK. London, United Kingdom: cancer research 2014. Available from: www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/incidence/#source9
   Google Scholar
• Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000;85:60-7
   PubMed Web of Science ®Google Scholar
• Cancer Statistics Registrations, England. Office for national statistics. National Statistical Institute, London, UK; 2001. Available from: www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations–england–series-mb1-/no–42–2011/index.html
   Google Scholar
• Neal D, Donovan J, Martin R, et al. Screening for prostate cancer remains controversial. Lancet 2009;374(9700):1482-3
   Google Scholar
• Braya F, Lortet-Tieulenta J, Ferlaya J, et al. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 2010;46(17):3040-52
   Google Scholar
• Prostate cancer: diagnosis and treatment, NICE clinical guideline 175. National Institute for Health Care and Excellence, London, UK. Available from: www.nice.org.uk/nicemedia/live/14348/66226/66226.pdf
   Google Scholar
• Braun DP, Gupta D, Staren ED. Predicting survival in prostate cancer: the role of quality of life assessment. Support Care Cancer 2012;20:1267-74
   PubMed Web of Science ®Google Scholar
• Buhmeida A, Pyrhönen S, Laato M, et al. Prognostic factors in prostate cancer. Diag Path 2006;1:4. Available from: www.diagnosticpathology.org/content/1/1/4
   PubMed Web of Science ®Google Scholar
• Garth A, Green MD, Alexandra L, et al. A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy. Cancer 1998;83(5):971-6
   Google Scholar
• William K, Hurwitz M, D’Amico A, et al. Biology of prostate cancer. BC Decker; Hamilton, ON: 2003
   Google Scholar
• Onur R, Littrup PJ, Pontes JE, et al. Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol 2004;172(2):512-14
   Google Scholar
• Harvey CJ, Pilcher J, Richenberg J, et al. Applications of transrectal ultrasound in prostate cancer. Br J Radiol 2012;85:3-17
   PubMedGoogle Scholar
• Halpern E. Contrast-enhanced ultrasound imaging of prostate cancer. Rev Urol 2006;8(1):29-37
   Google Scholar
• McNeal JE. Origin and development of carcinoma in the prostate. Cancer 1969;23(1):24-34
   PubMed Web of Science ®Google Scholar
• Undertaking a transrectal ultrasound guided biopsy of the prostate. NHS Cancer Screening Programme, Sheffield, UK. Cancer screening Available from: www.cancerscreening.nhs.uk/prostate/pcrmp01.pdf
   Google Scholar
• Transrectal ultrasound guided prostate biopsy. UCSF Urology. University of California : San Francisco. Department of Urology. Available from: http://urology.ucsf.edu/sites/urology.ucsf.edu/files/uploaded-files/attachments/transrectal_ultrasound_guided_prostate_biopsy.pdf
   Google Scholar
• Davis M, Sofer M, Sandy S, et al. The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 2002;167(2):566-70
   PubMedGoogle Scholar
• Rodriguez L, Terris M. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the Literature. J Urol 1998;160(6):2115-20
   Google Scholar
• Djavan B, Waldert M, Zlotta A, et al. Safety and morbidity of first and repeat transrectal ultrasound needle biopsies: results of a prospective European Prostate Cancer Study. J Urol 2001;166(3):856-60
   PubMed Web of Science ®Google Scholar
• Nam RK, Saskin R, Lee Y, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2013;189(1):12-17
   Google Scholar
• Toren P, Razik R, Trachtenberg J. Catastrophic sepsis and hemorrhage following transrectal ultrasound guided prostate biopsies. Can Urol Assoc J 2010;4(1):12-14
   Google Scholar
• Borer A, Gilad J, Sikuler E, et al. Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J Infect 1999;38(2):128-9
   Google Scholar
• Duffield AS, Lee TK, Miyamoto H, et al. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. J Urol 2009;182(5):2274-8
   PubMed Web of Science ®Google Scholar
• PROMIS. Evaluation of multi-parametric magnetic resonance imaging in the diagnosis and characterisation of prostate cancer. University College of London, London, UK: Clinical trials unit. Available from: www.ctu.mrc.ac.uk/plugins/StudyDisplay/protocols/PROMIS%20Protocol%20and%20Appendices%20v4.0%2006%20September%202013%20with%20coversheets.pdf
   Google Scholar
• Krughoff K, Eid K, Phillips J, et al. The Accuracy of prostate cancer localization diagnosed on transrectal ultrasound-guided biopsy compared to 3-dimensional transperineal approach. Adv Urol 2013; Available from: http://dx.doi.org/10.1155/2013/249080
   Google Scholar
• Nafie S, Mellon JK, Dormer JP, et al. The role of transperineal template prostate biopsies in prostate cancer diagnosis in biopsy naïve men with PSA less than 20 ng ml−1. Prostate Cancer Prostatic Dis 2014;17(2):170-3
   Google Scholar
• Onik G, Miessau M, Bostwick D. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol 2009;27(26):4321-6
   PubMed Web of Science ®Google Scholar
• Ekwueme K, Simpson H, Zakhour H, et al. Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy. BJU Int 2013;111(8):E365-73
   Google Scholar
• Kepner GR, Kepner JV. Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies. Theor Biol Med Model 2010;7:23
   Google Scholar
• Onik G, Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008;26(5):506-10
   PubMed Web of Science ®Google Scholar
• Pal RP, Elmussareh M, Chanawani M, et al. The role of a standardized 36 core template assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies. BJU Int 2011;109(3):367-71
   Google Scholar
• Barzell WE, Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate–a 4-year experience. Urology 2007;70:27
   PubMed Web of Science ®Google Scholar
• Kasivisvanathan V, Dufour R, Moore CM, et al. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol 2013;189(3):860-6
   Google Scholar
• Ahmed HU, Hu Y, Carter T, et al. Characterizing clinically significant prostate cancer using template prostate mapping biopsy. J Urol 2011;186:458
   Google Scholar
• Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011;59:477
   PubMed Web of Science ®Google Scholar
• Surgical site infection: prevention and treatment of surgical site infection, NICE clinical guideline 74. National Institute for Health Care and Excellence, London, UK. Available from: www.nice.org.uk/nicemedia/live/11743/42379/42379.pdf
   Google Scholar
• Shepard J, Ward W, Milstone A, et al. Financial impact of surgical site infections on hospitals: the hospital management perspective. JAMA Surg 2013;148(10):907-14
   PubMed Web of Science ®Google Scholar
• El-Hakim A, Moussa S. CUA guidelines on prostate biopsy methodology. Can Urol Assoc J 2010;4(2):89-4
   Google Scholar
• Shigehara K, Miyagi T, Nakashima T, et al. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother 2008;14(1):40-3
   Google Scholar
• Dimmen M, Vlatkovic L, Hole K, et al. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int 2011;110:69-75
   Google Scholar
• Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 2000;164:76-80
   PubMed Web of Science ®Google Scholar
• Robert-Ebadi H, Le Gal G, Righini M. Use of anticoagulants in elderly patients: practical recommendations. Clin Interv Aging 2009;4:165-77
   PubMed Web of Science ®Google Scholar
• Smith JB, Popert R, Nuttall MC, et al. Transperineal sector prostate biopsies: a local anesthetic outpatient technique. Urology 2014;83(6):1344-9
   Google Scholar
• Bittner N, Merrick GS, Andreini H, et al. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB. Urology 2009;74(1):171-6
   PubMed Web of Science ®Google Scholar
• Pepe P, Aragona F. Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 2013;81(6):1142-6
   PubMed Web of Science ®Google Scholar
• Bittner N, Merrick GS, Butler WM, et al. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy. J Urol 2013;190(2):509-14
   Google Scholar
• Zaytoun OM, Stephenson AJ, Fareed K, et al. When serial prostate biopsy is recommended: most cancers detected are clinically insignificant. BJU Int 2012;110(7):987-92
   Google Scholar
• Klatte T, Swietek N, Schatzl G, et al. Transperineal template-guided biopsy for diagnosis of prostate cancer in patients with at least two prior negative biopsies. Wien Klin Wochenschr 2013;125:669-73
   Google Scholar
• Gershman B, Zietman A, Feldman A, et al. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol Oncol 2013;31:1093-7
   Google Scholar
• Mabjeesh N, Lidawi G, Chen J, et al. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int 2012;110:993-7
   PubMed Web of Science ®Google Scholar
• Barzell WE, Melamed MR, Cathcart P, et al. Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favourable risk prostate cancer. J Urol 2012;188:762-8
   PubMed Web of Science ®Google Scholar
• Taira A, Merrick G, Galbreath R, et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 2010;13:71-7
   PubMed Web of Science ®Google Scholar
• Crawford ED, Rove KO, Barqawi AB, et al. Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens. Prostate 2013;73:778-87
   PubMed Web of Science ®Google Scholar
• Huo AS, Hossack T, Symons JLP, et al. Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: a comparison with radical prostatectomy specimens. J Urol 2012;187:2044-50
   Google Scholar
• Moran B, Braccioforte M. Stereotactic transperineal prostate biopsy. Urology 2009;73:386-8
   Google Scholar
• Eggener S, Scardino P, Carroll P, et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007;178:2260-7
   PubMed Web of Science ®Google Scholar
• Crouzet S, Rouviere O, Martin X, et al. High-intensity focused ultrasound as focal therapy of prostate cancer. Curr Opin Urol 2014;24(3):225-30
   Web of Science ®Google Scholar
• Losa A, Gaddaa G, Lazzeria M, et al. Complications and quality of life After template-assisted transperineal prostate biopsy in patients eligible for focal therapy. Urology 2013;81(6):1291-6
   PubMed Web of Science ®Google Scholar
• Tsivianemail M, Abern M, Qi P, et al. Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy. Urology 2013;82(1):166-70
   Google Scholar
• Willis S, Bott S, Montgomery B. Urinary retention following transperineal template prostate biopsy – study of risk factors. J Clin Urol 2013;6:55-8
   Google Scholar
• Symons JL, Huo A, Yuen CL, et al. Outcomes of transperineal template-guided prostate biopsy in 409 patients. BJU Int 2013;112(5):585-93
   PubMed Web of Science ®Google Scholar
• Merrick G, Taubenslag W, Andreini H, et al. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 2008;101(12):1524-9
   PubMed Web of Science ®Google Scholar
• D’Amico AV, Whittington R, Molkowics SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969-74
   PubMed Web of Science ®Google Scholar
• Graham J, Baker M, Macbeth F, Titshall V. Diagnosis and treatment of prostate cancer: summary of NICE guidance. BMJ 2008;336:610-12
   PubMed Web of Science ®Google Scholar
• Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol 2003;170:s21-5
   PubMed Web of Science ®Google Scholar
• Mohler J, Bohnson RR, Boston B, et al. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2010;8:162-200
   PubMed Web of Science ®Google Scholar
• Horwich A, Parker C, Bangma C, Kataja V. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21:v129-33
   PubMedGoogle Scholar